HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Sales, Distributor Data Refute Pyramid-Scheme Allegation, Execs Say

This article was originally published in The Rose Sheet

Executive Summary

Despite regulatory investigations prompted in part by activist investor Bill Ackman, Herbalife reported its 18th consecutive earnings period of record sales, executives with the direct seller say. First-quarter global sales increased 12.4% to $1.3 billion with growth in five of the firm’s six regions.

You may also be interested in...



Lights, Action, Invest: Icahn Casts Ackman As Herbalife 'Obsessive'

William Ackman "may be a smart guy but … he’s developed a very bad case of 'Herbalife obsession'," says Carl Icahn. Herbalife, meanwhile, offers videos on Ackman's "motives."

China Probe Finds Issues With Nu Skin Compliance, Not Business Model

Nu Skin’s direct-selling model in China, the legality of which some investors have questioned, was not cited in fines levied on the company totaling $540,000. Firm says it “is not aware of any other material enforcement investigations currently pending” in the country, which accounted for nearly half of Nu Skin’s fiscal 2013 fourth-quarter sales.

Herbalife Works To Rewrite Pyramid-Scheme Narrative, Improve Transparency

The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, is in fact essential to helping people lose weight and adopt healthy lifestyles. Herbalife is implementing changes to clarify its business model for investors.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel